{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T13:31:25Z","timestamp":1776519085578,"version":"3.51.2"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.2515\/therapie\/2013072","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T10:00:10Z","timestamp":1402653610000},"page":"143-147","source":"Crossref","is-referenced-by-count":3,"title":["Baclof\u00e8ne et cirrhose : analyse de la litt\u00e9rature et pr\u00e9cautions d\u2019emploi adopt\u00e9es au sein du dispositif CAMTEA"],"prefix":"10.1016","volume":"69","author":[{"given":"Benjamin","family":"Rolland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Deheul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Cottencin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gis","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.2515\/therapie\/2013072_bb1195","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1360-0443.2011.03752.x","article-title":"Alcohol-dependence: the current French craze for baclofen","volume":"107","author":"Rolland","year":"2012","journal-title":"Addiction"},{"key":"10.2515\/therapie\/2013072_bb1200","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Rapport du comit\u00e9 technique de pharmacovigilance CT012013023, s\u00e9ance du 16 avril 2013. http:\/\/ansm.sante.fr\/content\/download\/52485\/676187\/version\/2\/file\/CR_CT012013023_Pharmacovigilance.pdf Consult\u00e9 le 12 novembre 2013 (18 pages)."},{"key":"10.2515\/therapie\/2013072_bb1205","article-title":"Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns-A cohort study","author":"Dupouy","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.2515\/therapie\/2013072_bb1210","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Mise en garde sur l\u2019utilisation hors-AMM du baclof\u00e8ne dans le traitement de l\u2019alcoolo-d\u00e9pendance - Point d\u2019information juin 2011. http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/b88517d4324d10054712c930f22c464b.pdf Consult\u00e9 le 12 novembre 2013 (3 pages)"},{"key":"10.2515\/therapie\/2013072_bb1215","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Utilisation du baclof\u00e8ne dans le traitement de l\u2019alcoolo-d\u00e9pendance: actualisation - Point d\u2019information avril 2012. http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/91de532b62ae44bfc7c2d54ec5b08e9a.pdf Consult\u00e9 le 12 novembre 2013 (5 pages)."},{"issue":"10","key":"10.2515\/therapie\/2013072_bb1220","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40263-013-0109-3","article-title":"Comment on: \u00ab Management of alcohol dependence in patients with liver disease \u00bb","volume":"27","author":"Rolland","year":"2013","journal-title":"CNS Drugs"},{"issue":"6","key":"10.2515\/therapie\/2013072_bb1225","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2515\/therapie\/2010073","article-title":"Un dispositif de prescription hors-AMM : exemple du baclof\u00e8ne","volume":"65","author":"Rolland","year":"2010","journal-title":"Therapie"},{"key":"10.2515\/therapie\/2013072_bb1230","unstructured":"Villier C, Schir E, Mallaret M. Effets ind\u00e9sirables du baclof\u00e8ne dans le traitement des addictions. Suivi national de pharmacovigilance : ann\u00e9e 2011. Comit\u00e9 technique de pharmacovigilance de mars 2012. http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/264282cafe82f9e1f08323df4722fda1.pdf Consult\u00e9 le 12 novembre 2013 (21 pages)"},{"issue":"9603","key":"10.2515\/therapie\/2013072_bb1235","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.2515\/therapie\/2013072_bb1240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ana.410170202","article-title":"Antispasticity drugs: mechanisms of action","volume":"17","author":"Davidoff","year":"1985","journal-title":"Ann Neurol"},{"issue":"5","key":"10.2515\/therapie\/2013072_bb1245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jat\/27.5.275","article-title":"Direct and rapid determination of baclofen (Lioresal) and carisoprodol (Soma) in bovine serum by liquid chromatographymass spectrometry","volume":"27","author":"Miksa","year":"2003","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.2515\/therapie\/2013072_bb1250","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.ajkd.2011.12.032","article-title":"Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis","volume":"59","author":"Fagundes","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.2515\/therapie\/2013072_bb1255","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2515\/therapie\/2012070","article-title":"Traitement par doses \u00e9lev\u00e9es de baclof\u00e8ne \u00e0 l\u2019origine d\u2019un surdosage chez un \u00e9thylique chronique insuffisant r\u00e9nal","volume":"67","author":"G\u00e9gu","year":"2012","journal-title":"Therapie"},{"key":"10.2515\/therapie\/2013072_bb1260","doi-asserted-by":"crossref","first-page":"642108","DOI":"10.1155\/2012\/642108","article-title":"Pathogenesis of hepatic encephalopathy","volume":"2012","author":"Cie\u0107ko-Michalska","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.2515\/therapie\/2013072_bb1265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.abb.2013.04.005","article-title":"GABAergic transmission in hepatic encephalopathy","volume":"536","author":"Sergeeva","year":"2013","journal-title":"Arch Biochem Biophys"},{"issue":"18","key":"10.2515\/therapie\/2013072_bb1270","doi-asserted-by":"crossref","first-page":"18840","DOI":"10.1074\/jbc.M313470200","article-title":"Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking","volume":"279","author":"Balasubramanian","year":"2004","journal-title":"J Biol Chem"},{"issue":"3","key":"10.2515\/therapie\/2013072_bb1275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(90)90269-C","article-title":"Central GABAA excitatory and GABAB inhibitory receptors regulate gastric acid secretion in rats","volume":"177","author":"Del Tacca","year":"1990","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.2515\/therapie\/2013072_bb1280","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.2515\/therapie\/2013072_bb1285","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40263-013-0043-4","article-title":"Management of alcohol dependence in patients with liver disease","volume":"27","author":"Addolorato","year":"2013","journal-title":"CNS Drugs"},{"key":"10.2515\/therapie\/2013072_bb1290","unstructured":"Baclofen for the treatment of alcohol drinkers (BACLOVILLE). Study record detail. ClinicalTrials.gov Identifier: NCT01604330. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01604330 Consult\u00e9 le 12 novembre 2013."},{"key":"10.2515\/therapie\/2013072_bb1295","unstructured":"Efficacy and safety of baclofen for maintenance of abstinence in alcohol dependent patients (ALPADIR). Study record detail. ClinicalTrials.gov Identifier: NCT01738282. http:\/\/clinicaltrials.gov\/show\/NCT01738282 Consult\u00e9 le 12 novembre 2013."}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716309714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716309714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:48:24Z","timestamp":1554277704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716309714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0040595716309714"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2013072","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}